| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Exozymes Inc. (EXOZ) has 5 insiders with recent SEC Form 4 filings, including 4 buys and 0 sells. EXOZ is classified in the Biotechnology industry within the Healthcare sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 730.6K | $8.33M | - | |
| VP | 645.1K | $7.35M | - | |
| Other | 146.4K | $1.67M | - | |
| CEO | 10.6K | $121.2K | - | |
| VP | 9.5K | $108.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 2, 2025 | Heltzen Michael | Chief Executive Officer | Buy | 1,040 | $10.22 | $10,628.80 | +10.8% | |
| Jan 17, 2025 | Heltzen Michael | Chief Executive Officer | Buy | 1,888 | $10.78 | $20,345.38 | +46.2% | |
| Nov 15, 2024 | Heltzen Michael | Chief Executive Officer | Buy | 1,984 | $11.10 | $22,022.40 | New |